Cost? Check with your insurance company or healthcare provider for information about costs for mAb services.
MAbs are authorized by the FDA to treat patients with mild to moderate COVID-19. The treatments are done by intravenous (IV) infusion in an outpatient setting. Therapeutic antibody treatments play an important role in Louisiana's ongoing COVID-19 response.
|Patient Information||Provider Information|
- Fact Sheet: Louisiana Department of Health Monoclonal Antibody Treatment for COVID-19
- Questions and Answers
- CDC: Monoclonal Antibodies: Treatments Your Healthcare Provider Might Recommend if You Are Sick
- CDC: Spreading the Word on the Benefits of Monoclonal Antibodies for COVID-19
- FDA Authorizes Monoclonal Antibody for Treatment of COVID-19